175 related articles for article (PubMed ID: 7540458)
21. The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia.
Ivancević TD; Kurtović NK; Knezević V; Bogdanović A; Mihaljević B; Bozić B; Gotić M
Srp Arh Celok Lek; 2014; 142(3-4):197-203. PubMed ID: 24839775
[TBL] [Abstract][Full Text] [Related]
22. The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias.
Hanson CA; Morice WG
Am J Hematol; 2008 May; 83(5):347-8. PubMed ID: 18383327
[No Abstract] [Full Text] [Related]
23. CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL).
Faguet GB; Marti GE; Agee JF; Bertin P
Ann N Y Acad Sci; 1992 May; 651():470-3. PubMed ID: 1376063
[No Abstract] [Full Text] [Related]
24. Morphological and immunophenotypic features of chronic lymphocytic leukemia.
Matutes E; Polliack A
Rev Clin Exp Hematol; 2000 Mar; 4(1):22-47. PubMed ID: 11486329
[TBL] [Abstract][Full Text] [Related]
25. Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia.
Musolino C; Alonci A; Allegra A; Di Cesare E; Orlando A; Grosso P; Buda G; Squadrito G
Int J Hematol; 1992 Dec; 56(3):213-7. PubMed ID: 1477333
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
[TBL] [Abstract][Full Text] [Related]
27. CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases.
Cartron G; Linassier C; Bremond JL; Desablens B; Georget MT; Fimbel B; Luthier F; Dutel JL; Lamagnere JP; Colombat P
Leuk Lymphoma; 1998 Sep; 31(1-2):209-16. PubMed ID: 9720730
[TBL] [Abstract][Full Text] [Related]
28. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
[TBL] [Abstract][Full Text] [Related]
29. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
[TBL] [Abstract][Full Text] [Related]
31. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
[TBL] [Abstract][Full Text] [Related]
32. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
33. The importance of surface immunoglobulin, mouse rosettes, and CD5 in the immunophenotyping of chronic lymphocytic leukemia and reactive lymphocytosis.
Batata A; Shen B
Cancer; 1991 Jul; 68(2):355-61. PubMed ID: 2070335
[TBL] [Abstract][Full Text] [Related]
34. The prognostic role of CD5 negativity in B-cell chronic lymphocytic leukaemia: a case-control study.
Efstathiou S; Tsioulos D; Zacharos I; Tsiakou A; Mastorantonakis S; Salgami E; Katirtzoglou N; Psarra A; Roussou P
Haematologia (Budap); 2002; 32(3):209-18. PubMed ID: 12611481
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of bone-marrow pattern and immunophenotypic score in B-chronic lymphocytic leukemia at diagnosis.
Jahic A; Iljazovic E; Arnautovic-Custovic A; Halilbasic A; Simendic V; Zabic A
Med Arh; 2011; 65(3):132-6. PubMed ID: 21776871
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly.
Ghia P; Prato G; Scielzo C; Stella S; Geuna M; Guida G; Caligaris-Cappio F
Blood; 2004 Mar; 103(6):2337-42. PubMed ID: 14630808
[TBL] [Abstract][Full Text] [Related]
37. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
Moreau EJ; Matutes E; A'Hern RP; Morilla AM; Morilla RM; Owusu-Ankomah KA; Seon BK; Catovsky D
Am J Clin Pathol; 1997 Oct; 108(4):378-82. PubMed ID: 9322589
[TBL] [Abstract][Full Text] [Related]
38. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
39. Cleaved lymphocytes in chronic lymphocytic leukemia: a detailed retrospective analysis of diagnostic features.
Gonzalez H; Maloum K; Remy F; Merle-Béral H; Lesty C
Leuk Lymphoma; 2002 Mar; 43(3):555-64. PubMed ID: 12002759
[TBL] [Abstract][Full Text] [Related]
40. Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters.
Jurisic V; Colovic N; Kraguljac N; Atkinson HD; Colovic M
Med Oncol; 2008; 25(3):315-22. PubMed ID: 18183502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
